LeMaitre director exercises 2,941 stock options

LeMaitre Vascular director Joseph P. Pellegrino Jr. exercised stock options to acquire 2,941 shares of Common Stock at $35.48 per share.

Rhea-AI Filing Summary

LeMaitre Vascular director Joseph P. Pellegrino Jr. exercised stock options to acquire 2,941 shares of Common Stock at $35.48 per share. These shares came from a fully vested option that was exercised in full, leaving no remaining derivative position from this grant. Following the transaction, he directly owns 15,021 Common shares, making this a routine compensation-related option exercise rather than an open-market purchase or sale.

Insider Trade Summary

2,941 shares exercised/converted

Exercise 2 txns

Insider Pellegrino Joseph P JR

Role Director

Type	Security	Shares	Price	Value
Exercise	Stock Option (Right to Buy)	2,941	$0.00	$0.00
Exercise	Common Stock	2,941	$35.48	$104K

Holdings After Transaction: Stock Option (Right to Buy) — 0 contracts (Direct); Common Stock — 15,021 shares (Direct)

Footnotes (2)

1. F1. Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II.
2. F2. This option is fully vested and exercisable.

Key Figures

Options exercised: 2,941 shares Exercise price: $35.48 per share Shares owned after: 15,021 shares +3 more

6 metrics

Options exercised 2,941 shares Common Stock acquired via option exercise on 2026-04-22

Exercise price $35.48 per share Conversion or exercise price of Stock Option (Right to Buy)

Shares owned after 15,021 shares Total Common Stock directly held following the transaction

Exercised option size 2,941 derivative shares Underlying Common Stock for the Stock Option (Right to Buy)

Option expiration 2026-12-20 Expiration date of the exercised stock option grant

Option fully vested Yes Footnote states the option is fully vested and exercisable

Key Terms

Stock Option (Right to Buy), Exercise or conversion of derivative security, Common Stock, Form 4, +1 more

5 terms

Stock Option (Right to Buy) financial

"security_title: Stock Option (Right to Buy) with 2,941 underlying shares"

Exercise or conversion of derivative security regulatory

"transaction_code_description: Exercise or conversion of derivative security"

Common Stock financial

"security_title: Common Stock acquired upon exercise of options"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

Form 4 regulatory

"INSIDER FILING DATA (Form 4) reporting director’s transactions"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

fully vested and exercisable financial

"footnote: This option is fully vested and exercisable."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did LeMaitre Vascular (LMAT) report for Joseph P. Pellegrino Jr.?

Joseph P. Pellegrino Jr., a director of LeMaitre Vascular, exercised stock options to acquire 2,941 shares of Common Stock. The options were fully vested, and this transaction represents a derivative exercise rather than an open-market purchase or sale of shares.

At what price did the LeMaitre Vascular (LMAT) director exercise his stock options?

The director exercised stock options with an exercise price of $35.48 per share for 2,941 underlying Common shares. This price reflects the option’s conversion or exercise price and does not represent an open-market trading price on the exercise date.

How many LeMaitre Vascular (LMAT) shares does the director hold after this Form 4 transaction?

After exercising options for 2,941 shares, the director holds 15,021 shares of LeMaitre Vascular Common Stock directly. This total reflects his position following the reported transaction and shows his continuing equity stake in the company after the option exercise.

Did the LeMaitre Vascular (LMAT) Form 4 include any stock sales or gifts?

The Form 4 reports no stock sales, gifts, or tax-withholding dispositions. It shows only an option exercise that increased the director’s Common Stock holdings. Transaction summary data indicate acquire and exercise activity, with no sell, gift, or restructuring transactions reported.

What happened to the exercised LeMaitre Vascular (LMAT) stock options after the transaction?

The stock option covering 2,941 shares was fully exercised, leaving zero derivative shares following the transaction. Footnotes note the option was fully vested and exercisable, and post-transaction data show no remaining position from this particular option grant in the derivative table.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/23/2026 - 07:53 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Pellegrino Joseph P JR

(Last) (First) (Middle)

C/O LEMAITRE VASCULAR, INC.

63 SECOND AVENUE

(Street)

BURLINGTON MASSACHUSETTS 01803

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
LEMAITRE VASCULAR INC [ LMAT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/22/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	04/22/2026		M		2,941(1)	A	$35.48	15,021	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$35.48	04/22/2026		M			2,941	12/20/2019(2)	12/20/2026	Common Stock	2,941	$0	0	D

Explanation of Responses:

1. Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II.

2. This option is fully vested and exercisable.

	/s/ Laurie A. Churchill, Attorney-in-fact	04/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)